A recent press release from the National Institutes of Health calls attention to a study, published in Stem Cell Reports, that researchers have “developed a clinical-grade stem cell line, which has the potential to accelerate the advance of new medical applications and cell-based therapies for millions of people suffering from such ailments as Alzheimer’s disease, Parkinson’s disease, spinal cord injury, diabetes, and muscular dystrophy.” The development of these clinical grade stem cells, the release notes, “removes a significant barrier in the development of cell-based therapies.” But is NIH’s promotion of “stem cells” anything new?
Abortion ends the life of a unique human being. Children in Oklahoma public schools will learn that lesson beginning this fall.
Recently, the Atlantic published an article entitled “Why America is a Global Outlier on Abortion.” The author, Olga Khazan, wrote that the United States stands apart from the rest of the developed world due to restrictions to public funding of abortion.
Last Wednesday, the House of Representatives voted to pass the Conscience Protection Act of 2016 (S. 304) by 245-182.
In June, while the U.S. Supreme Court was sentencing women to the modern-day abortion back alley, Kentucky’s Court of Appeals unanimously, though temporarily, stopped EMW Women’s Clinic from performing abortions.